Skorski T - Search Results

1

PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions.

Podszywalow-Bartnicka P, Maifrede S, Le BV, Nieborowska-Skorska M, Piwocka K, Skorski T. Podszywalow-Bartnicka P, et al. Among authors: skorski t. Leuk Lymphoma. 2019 Jan;60(1):262-264. doi: 10.1080/10428194.2018.1471602. Epub 2018 Jun 22. Leuk Lymphoma. 2019. PMID: 29932782 Free PMC article. No abstract available.

2

A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice.

Skórski T, Nieborowska-Skórska M, Calabretta B. Skórski T, et al. Folia Histochem Cytobiol. 1992;30(3):91-6. Folia Histochem Cytobiol. 1992. PMID: 1286728

3

[Use of autologous bone marrow transplants in the treatment of neoplasms].

Nieborowska-Skórska M, Skórski T. Nieborowska-Skórska M, et al. Among authors: skorski t. Wiad Lek. 1988 Mar 15;41(6):383-9. Wiad Lek. 1988. PMID: 3066014 Review. Polish. No abstract available.

4

Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes.

Skorski T, Nieborowska-Skorska M, Campbell K, Iozzo RV, Zon G, Darzynkiewicz Z, Calabretta B. Skorski T, et al. J Exp Med. 1995 Dec 1;182(6):1645-53. doi: 10.1084/jem.182.6.1645. J Exp Med. 1995. PMID: 7500009 Free PMC article.

5

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.

Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, Calabretta B. Skorski T, et al. Blood. 1995 Jul 15;86(2):726-36. Blood. 1995. PMID: 7606002 Free article.

6

C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis.

Skorski T, Nieborowska-Skorska M, Szczylik C, Kanakaraj P, Perrotti D, Zon G, Gewirtz A, Perussia B, Calabretta B. Skorski T, et al. Cancer Res. 1995 Jun 1;55(11):2275-8. Cancer Res. 1995. PMID: 7757976

7

The role of c-Myc protooncogene in chronic myelogenous leukemia.

Nieborowska-Skórska M, Ratajczak MZ, Calabretta B, Skórski T. Nieborowska-Skórska M, et al. Among authors: skorski t. Folia Histochem Cytobiol. 1994;32(4):231-4. Folia Histochem Cytobiol. 1994. PMID: 7758616

8

Oncogene-targeted antisense oligodeoxynucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment?

Nieborowska-Skórska M, Nakashima M, Ratajczak M, Steplewski Z, Calabretta B, Skórski T. Nieborowska-Skórska M, et al. Among authors: skorski t. Folia Histochem Cytobiol. 1994;32(1):35-40. doi: 10.1007/BF02693351. Folia Histochem Cytobiol. 1994. PMID: 8026602

9

Successful mafosfamide purging of bone marrow from chronic myelogenous leukemia (CML) cells.

Nieborowska-Skórska M, Skórski T, Ratajczak MZ, Szczylik C, Malaguarnera L, Calabretta B. Nieborowska-Skórska M, et al. Among authors: skorski t. Folia Histochem Cytobiol. 1993;31(4):161-7. Folia Histochem Cytobiol. 1993. PMID: 8137996

10

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.

Skorski T, Nieborowska-Skorska M, Nicolaides NC, Szczylik C, Iversen P, Iozzo RV, Zon G, Calabretta B. Skorski T, et al. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4504-8. doi: 10.1073/pnas.91.10.4504. Proc Natl Acad Sci U S A. 1994. PMID: 8183938 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters